Moreover, it has been reported that polymorphisms in GEMIN4 gene were related to the etiology as well as clinical outcome of multiple cancers like renal carcinoma [24], bladder cancer [25] and ovarian cancer [26]. This evidence concerns the gene GEMIN4 and urinary bladder carcinoma.